Atlas FDA

Exablate Model 400 Type 1.0 & Type 1.1, Exablate Transcranial MRgFUS, Exablate Neuro, Exablate TcMRgFUS, Exablate Neurav

FDA premarket approval P150038/S028 · decided 2023-07-27

Approval details

PMA number
P150038
Supplement
S028
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Exablate Model 400 Type 1.0 & Type 1.1, Exablate Transcranial MRgFUS, Exablate Neuro, Exablate TcMRgFUS, Exablate Neurav
Generic name
MR-guided focused ultrasound system
Applicant
Insightec
Date received
2023-06-27
Decision date
2023-07-27
Days to decision
30 days
Decision code
OK30
Product code
POH
Advisory committee
Neurology
Expedited review
No
Location
Tirat Carmel
Statement
Change to allow fully automated assembly of the coil isolation board PCB layout.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.